Against Chikungunya Virus and Neonatal Infection

Abroad (travel likely)Recruiting

Conditions

Chikungunya Virus Infection · Neonatal · Transfusion · Encephalopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU La Réunion, Saint-Pierre, France
IACOBELLI · promotion.drci@chu-reunion.fr · +262262359000
Contact: Principal Investigator (Duksha RAMFUL, Dr)
Contact: Principal Investigator (Soumeth ABASSE, Dr)
Contact: Principal Investigator (Silvia IACOBELLI, Pr)
Centre hospitalier de Mayotte, Mamoudzou, Mayotte
Contact: Study coordinator (Soumeth ABASSE) · nouriati.toumbou@chmayotte.fr · +262 269 61 80 00

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults

Chikungunya Virus

Abroad (travel likely)RecruitingPHASE3

Cebu City, Philippines · Kamphaeng Phet, Thailand

A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.

Active Immunisation for Chikungunya Virus Infection

Abroad (travel likely)RecruitingPHASE2, PHASE3

Guwahati, India · Patna, India

A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.

Chikungunya Virus

Abroad (travel likely)RecruitingPHASE3

Fountain Valley, United States · Washington D.C., United States

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Dengue · Chikungunya · Zika Virus Infection

Abroad (travel likely)Recruiting

Phnom Penh, Cambodia